| 产品描述: | SCH 336 是一种有效的、选择性的、反向的和具有口服活性的 CB2 激动剂。SCH 336 抑制 BaF3/CB2 细胞迁移。SCH 336 显着抑制体内白细胞的迁移。SCH 336 可阻断卵白蛋白诱导的小鼠肺嗜酸性粒细胞增多。 |
| 靶点: |
hCB2-R |
| 体外研究: |
SCH 336 (Sch.336) (0-10 µM) competes with [3H]CP55,940 for binding to human CB2 on Sf9 cell membranes with Ki of 1.8 nM, and decreases GTPγS binding on human CB2-containing membranes with an EC50 of 2 nM, decreases potency on CB1-containing membranes with EC50 of 200 nM. SCH 336 inhibits BaF3/CB2 migration to 100 nM 2-AG with an IC50 of 34 nM. |
| 体内研究: |
SCH 336 (0.02, 0.2, 2.0 mg/kg; i.p.) significantly inhibits the migration of leukocytes. |
| 参考文献: |
1. Lunn CA, et al. A novel cannabinoid peripheral cannabinoid receptor-selective inverse agonist blocks leukocyte recruitment in vivo. J Pharmacol Exp Ther. 2006 Feb;316(2):780-8. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.853 ml |
9.265 ml |
18.531 ml |
| 5 mM |
0.371 ml |
1.853 ml |
3.706 ml |
| 10 mM |
0.185 ml |
0.927 ml |
1.853 ml |
| 50 mM |
0.037 ml |
0.185 ml |
0.371 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |